[Summary] Developer of tumor immunotherapeutic drugs
Lepu Biopharmaceutical Technology Co., Ltd., established in preparation in January 2018, has a registered capital of 1 billion RMB. It has simultaneously invested in the construction of production bases for monoclonal antibodies in Shanghai and Beijing, and has made equity investments in various start-up companies involved in monoclonal antibody discovery, drug development, research, and production. Its main mission is to focus on tumor immunotherapy, developing and producing an innovative platform for tumor treatment products focusing on PD-1, PD-L1, and core combination therapies (oncolytic viruses, ADC). Additionally, it aims to build an open industrial platform for target discovery, drug development, research, and production. Through the synergy of the industrial platform and product platform, it aims to achieve leapfrog and sustainable development for Lepu Biopharmaceutical.
What does Lepu Biopharma Co., Ltd. require? Who is Lepu Biopharma hiring? Lepu Biopharma recruitment: Business Management占比最多占34.3%,其次是Sales占31.4%. What education can get in at Lepu Biopharma? 硕士占比最多占35.8%,其次是本科占32.1%. High education required at Lepu Biopharma? 硕士占35.8%,博士占3.6%. Work experience required at Lepu Biopharma? 3-5年占比最多占40.9%,其次是5-10年占28.5%. Where are the job locations at Lepu Biopharma? 上海占比最多占55.5%,其次是北京占21.2%. Based on job postings from the past year, for reference only.
Featuring 268 companies ,3 followers
Featuring 29 companies ,2 followers
Featuring 27 companies
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows